Please login to the form below

Not currently logged in
Email:
Password:

Owlstone Medical

This page shows the latest Owlstone Medical news and features for those working in and with pharma, biotech and healthcare.

Grail to initiate largest ever UK cancer screening study

Grail to initiate largest ever UK cancer screening study

That initiative builds on the 100, 000 Genome Project, and data from that could soon be integrated into medical records, a move which could help the UK's NHS become a ... Another firm active in the UK is Owlstone Medical, which is developing a Breath

Latest news

More from news
Approximately 2 fully matching, plus 0 partially matching documents found.

Latest appointments

  • Owlstone Medical bolsters management team Owlstone Medical bolsters management team

    Cambridge, UK-based diagnostics firm Owlstone Medical has added three business development, clinical research and manufacturing executives to its senior management team. ... Scanlon will be tasked with manufacturing the scale-up of Owlstone Medical's

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Skills in Healthcare

At Skills in Healthcare, we are able to provide our customers with a professional set of sales capabilities. With our...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics